Repurposing Drugs for COVID-19: An Approach for Treatment in the Pandemic.
Conclusions: Although current results are promising, limitations to drug repurposing, such as a low success rate and the possibility of adverse events, can't be overlooked. With continuous research and technical advancements, repurposing will no doubt provide a notable scientific contribution to innovation in drug development and pharmacotherapy practice for the treatment of new diseases or existing diseases in a new way.
PMID: 32827400 [PubMed - as supplied by publisher]
Source: Alternative Therapies in Health and Medicine - Category: Complementary Medicine Authors: Khadka S, Yuchi A, Shrestha DB, Budhathoki P, Al-Subari SMM, Ziad Alhouzani TM, Anwar Butt I Tags: Altern Ther Health Med Source Type: research
More News: Actemra | Alternative and Complementary Therapies | Azithromycin | Cancidas | Caspofungin | Complementary Medicine | COVID-19 | Databases & Libraries | Dexamethasone | Drugs & Pharmacology | Hydroxychloroquine | Kaletra | Nepal Health | Norvir | Oseltamivir | Pakistan Health | Pandemics | SARS | Study | Tamiflu | Zithromax